Frank Verwiel
CIK 1545794 · last filed 2026-06-10
Frank Verwiel is a corporate insider who has filed 25 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for NTLA, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$37.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $425.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$425.6K
3
25
-$37.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NTLA | Director | 35,148 | $12.11 | $425.6K | -$37.6K | 11 | 2026-06-10 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Director | — | — | — | $0 | 6 | 2020-01-29 |
| AveXis, Inc. (AVXS) Delisted | Director | 0 | — | — | $0 | 4 | 2018-05-15 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | NTLA | Grant (A) | +9,200 | $0 | EDGAR |
| 2025-06-13 | NTLA | Grant (A) | +8,000 | $0 | EDGAR |
| 2024-06-20 | NTLA | Sell (S) | −1,505 | -$37.6K | EDGAR |
| 2024-06-14 | NTLA | Grant (A) | +7,737 | $0 | EDGAR |
| 2023-06-16 | NTLA | Grant (A) | +4,425 | $0 | EDGAR |
| 2022-06-16 | NTLA | Grant (A) | +5,197 | $0 | EDGAR |
| 2021-06-25 | NTLA | Grant (A) | +2,094 | $0 | EDGAR |
| 2020-06-19 | NTLA | Grant (A) | — | $0 | EDGAR |
| 2020-01-29 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2019-05-22 | NTLA | Grant (A) | — | $0 | EDGAR |